Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

M Bolla, H van Poppel, B Tombal, K Vekemans, L Da Pozzo, TM de Reijke, A Verbaeys, JF Bosset, R van Velthoven, M Colombel, C (Cees) van Beek, Paul Verhagen, A Bergh, C Sternberg, T Gasser, G van Tienhoven, P Scalliet, K Haustermans, L Collette

Research output: Contribution to journalArticleAcademicpeer-review

685 Citations (Scopus)


Background We report the long-term results of a trial of immediate postoperative irradiation versus a wait-and-see policy in patients with prostate cancer extending beyond the prostate, to confirm whether previously reported progression-free survival was sustained. Methods This randomised, phase 3, controlled trial recruited patients aged 75 years or younger with untreated cT0-3 prostate cancer (WHO performance status 0 or 1) from 37 institutions across Europe. Eligible patients were randomly assigned centrally (1:1) to postoperative irradiation (60 Gy of conventional irradiation to the surgical bed for 6 weeks) or to a wait-and-see policy until biochemical progression (increase in prostate-specific antigen >0.2 mu g/L confirmed twice at least 2 weeks apar Findings 1005 patients were randomly assigned to a wait-and-see policy (n=503) or postoperative irradiation (n=502) and were followed up for a median of 10.6 years (range 2 months to 16.6 years). Postoperative irradiation significantly improved biochemical progression-free survival compared with the wait-and-see policy (198 [39.4%] of 502 patients in postoperative irradiation group vs 311 [61.8%] of 503 patients in wait-and-see group had biochemical or clinical progression or died; HR 0.49 [95% Interpretation Results at median follow-up of 10.6 years show that conventional postoperative irradiation significantly improves biochemical progression-free survival and local control compared with a wait-and-see policy, supporting results at 5 year follow-up; however, improvements in clinical progression-free survival were not maintained. Exploratory analyses suggest that postoperative irradiation might improve clinical progression-free survival in patients younger than 70 years and in those w
Original languageUndefined/Unknown
Pages (from-to)2018-2027
Number of pages10
JournalLancet (UK)
Issue number9858
Publication statusPublished - 2012

Research programs

  • EMC MM-03-49-01

Cite this